Bosh sahifaCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Yopilish kursi
7,50 $
Kunlik diapazon
7,20 $ - 8,58 $
Yillik diapazon
5,20 $ - 22,20 $
Bozor kapitalizatsiyasi
2,44 mln USD
Oʻrtacha hajm
4,55 ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 10,00 ming | -37,50% |
Joriy xarajat | 2,19 mln | -68,12% |
Sof foyda | -1,96 mln | 67,56% |
Sof foyda marjasi | -19,57 ming | 48,09% |
Har bir ulushga tushum | -0,18 | 97,55% |
EBITDA | -2,18 mln | 68,18% |
Amaldagi soliq stavkasi | 9,69% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,98 mln | -49,83% |
Jami aktivlari | 5,38 mln | -56,94% |
Jami passivlari | 6,35 mln | -22,55% |
Umumiy kapital | -970,00 ming | — |
Tarqatilgan aksiyalar | 6,29 mln | — |
Narxi/balansdagi bahosi | -16,67 | — |
Aktivlardan daromad | -80,21% | — |
Kapitaldan daromad | -32 014,71% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -1,96 mln | 67,56% |
Operatsiyalardan naqd pul | -3,07 mln | 24,01% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | -1,00 ming | 98,00% |
Naqd pulning sof oʻzgarishi | -3,02 mln | 28,48% |
Boʻsh pul | -2,31 mln | 8,20% |
Haqida
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow. Wikipedia
Tashkil etilgan
13-avg, 1996
Sayt
Xodimlar soni
12
